SCHEMBL3200647

SCHEMBL3200647

CCN(CC)c1ccc(C=O)c(OCc2ccc(C(C)(C)C)cc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
L3MBTL1 Q9Y468 3/20 0.58
BACE1 P56817 3/20 0.47
RAB9A P51151 1/20 0.45
CA9 Q16790 2/20 0.40
CCR5 P51681 1/20 0.40
HIF1A Q16665 1/20 0.39
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39
RXRA P19793 2/20 0.39
RXRB P28702 2/20 0.39
RXRG P48443 1/20 0.39
MAPT P10636 3/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
APP P05067 1/20 0.38
ALDH3A1 P30838 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6438701 0.86 ALDH1A1 (0.62) ALDH1A1L3MBTL1BACE1CA9CCR5
SCHEMBL3218793 0.85 ALDH1A1 (0.68) ALDH1A1L3MBTL1BACE1RAB9ACA9
SCHEMBL3200550 0.85 ALDH1A1 (0.63) ALDH1A1L3MBTL1BACE1RAB9ACA9
SCHEMBL13580768 0.80 PTGER1 (0.48) ALDH1A1L3MBTL1RAB9ACCR5RXRA
SCHEMBL3200409 0.79 BACE1 (0.79) BACE1MAPTAPP
SCHEMBL3200425 0.79 BACE1 (0.79) BACE1MAPTAPP
SCHEMBL5146907 0.79 ALDH1A1 (0.74) ALDH1A1L3MBTL1BACE1RAB9ACA9
SCHEMBL8684021 0.77 MRGPRX4 (0.48) L3MBTL1RAB9ARXRARXRBRXRG
SCHEMBL3220878 0.76 ALDH1A1 (0.55) ALDH1A1L3MBTL1BACE1CA9KMT2A
SCHEMBL8684017 0.76 ALDH1A1 (0.54) ALDH1A1L3MBTL1RAB9ARXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 ALDH1A1 253/4885L3MBTL1 2164/4885BACE1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.